Abstract
Karenitecin is a novel, highly lipophilic camptothecin derivative with potent anticancer potential. We have developed a sensitive high-performance liquid chromatographic method for the determination of karenitecin concentration in human plasma and urine. Karenitecin was isolated from human plasma and urine using solid-phase extraction. Separation was achieved by gradient elution, using a water and acetonitrile mobile phase, on an ODS analytical column. Karenitecin was detected using fluorescence detection at excitation and emission wavelengths of 370 and 490 nm, respectively. Retention time for karenitecin was 16.2±0.5 min and 8.0±0.2 min for camptothecin, the internal standard. The karenitecin peak was baseline resolved, with the nearest peak at 3.1 min distance. Using normal volunteer plasma and urine from multiple individuals, as well as samples from the 50 patients analyzed to date, no interfering peaks were detected. Inter- and intra-day coefficients of variance were
Original language | English (US) |
---|---|
Pages (from-to) | 117-124 |
Number of pages | 8 |
Journal | Journal of Chromatography B: Biomedical Sciences and Applications |
Volume | 759 |
Issue number | 1 |
DOIs | |
State | Published - Aug 5 2001 |
Externally published | Yes |
Keywords
- Camptothecin
- Karenitecin
ASJC Scopus subject areas
- Chemistry(all)